Thank you, Mr. Johns.
Thank you, Dr. Ghosh.
That concludes the rounds of questions for this panel. I want to sincerely thank you both for being with us. This has been extremely interesting and will undoubtedly be very valuable to us in our study. Thank you for being with us and sharing your expertise. You're welcome to stay, but you are free to go.
Colleagues, please don't run away. There's one update I have for you with regard to the calendar going forward.
Mr. Johns, I think, is going to seek to resume a motion that had been adjourned.
In terms of updates, this Thursday we'll commence the study of Bill C-277. That's a private member's bill from Alistair MacGregor. We will have a panel of witnesses that has been confirmed for Thursday. The sponsor of the bill will appear on October 10. Unless the direction of the committee has changed, we would propose to do clause-by-clause at a subsequent meeting, likely October 24.
With respect to the opioid study, we'll resume the opioid study on Tuesday of next week. We've gone with the work plan and invited the third panel. That's by way of update.
Now I recognize Mr. Johns, and then Mr. Doherty.